Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-09-19, Stock:LLY, The news for the past five days is as follows:
2018-09-12: NEWS1: Bristol-Myers (BMY) Reports Phase II Data on Psoriasis Drug.NEWS2: Bristol-Myers (BMY) Reports Phase II Data on Psoriasis Drug.NEWS3: AbbVie Gets FDA Nod for Venclexta Label Expansion in Leukemia.NEWS4: AbbVie Gets FDA Nod for Venclexta Label Expansion in Leukemia.NEWS5: Merck's Antibacterial Drug Succeeds in Label Expansion Study.NEWS6: Merck's Antibacterial Drug Succeeds in Label Expansion Study.NEWS7: Incyte, Foundation Medicine Partner for Companion Diagnostics.NEWS8: Incyte, Foundation Medicine Partner for Companion Diagnostics.NEWS9: Merck&apos;s Antibacterial Drug Succeeds in Label Expansion Study.NEWS10: AbbVie Gets FDA Nod for Venclexta Label Expansion in Leukemia.NEWS11: Bristol-Myers (BMY) Reports Phase II Data on Psoriasis Drug.NEWS12: Incyte, Foundation Medicine Partner for Companion Diagnostics.NEWS13: NCCN and Lilly Support Quality Improvements for Gastric Cancer Care.NEWS14: Eli Lilly To Present At Morgan Stanley Conference; Webcast At 1:40 PM ET.NEWS15: Eli Lilly To Present At Morgan Stanley Conference; Webcast At 1:40 PM ET.
2018-09-13: NEWS1: New Lilly Diabetes Center of Excellence Established at the Indiana Bioscience Research Institute.NEWS2: PJP, PFE, MRK, LLY: ETF Outflow Alert.NEWS3: PJP, PFE, MRK, LLY: ETF Outflow Alert.NEWS4: Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar?.NEWS5: Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar?.NEWS6: Why Eli Lilly (LLY) is a Great Dividend Stock.NEWS7: Why Eli Lilly (LLY) is a Great Dividend Stock.NEWS8: Why Eli Lilly (LLY) is a Great Dividend Stock.NEWS9: See what the IHS Markit Score report has to say about Eli Lilly And Co..
2018-09-14: NEWS1: Eli Lilly Is Selling More Shares of This Biopharma Firm.NEWS2: AstraZeneca's Lumoxiti Gets FDA Nod for Hairy Cell Leukemia.NEWS3: AstraZeneca's Lumoxiti Gets FDA Nod for Hairy Cell Leukemia.NEWS4: Roche's Child Arthritis Drug's New Formulation Gets FDA Nod.NEWS5: Roche's Child Arthritis Drug's New Formulation Gets FDA Nod.NEWS6: Pharma Stock Roundup: AZN&apos;s Leukemia Drug Wins FDA Nod, MRK&apos;s Keytruda in Focus.NEWS7: Roche&apos;s Child Arthritis Drug&apos;s New Formulation Gets FDA Nod.NEWS8: AstraZeneca&apos;s Lumoxiti Gets FDA Nod for Hairy Cell Leukemia.
2018-09-17: NEWS1: Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV.NEWS2: Analysts Raise Ratings on Teva Stock on Ajovy’s FDA Approval.NEWS3: How Pharmaceutical ETFs Have Performed in 2018.NEWS4: Competition Dynamics for Ajovy—Teva’s Migraine Drug.NEWS5: Allergan Frown Lines Study Passes Test on Higher Botox Dose.NEWS6: Allergan Frown Lines Study Passes Test on Higher Botox Dose.NEWS7: Teva's (TEVA) Migraine Drug Ajovy Receives FDA Approval.NEWS8: Teva's (TEVA) Migraine Drug Ajovy Receives FDA Approval.NEWS9: These Pharmaceutical Stocks Have Surpassed the S&P 500 in 2018.NEWS10: Teva stock surges 7% after FDA approves migraine medication.
2018-09-18: NEWS1: Bayer (BAYRY) Focuses on Acquisitions, Competition a Concern.NEWS2: Bayer (BAYRY) Focuses on Acquisitions, Competition a Concern.NEWS3: Does Ajovy's Approval Make Teva a Pain-Free Stock to Buy?.NEWS4: Does Ajovy's Approval Make Teva a Pain-Free Stock to Buy?.NEWS5: Bayer (BAYRY) Focuses on Acquisitions, Competition a Concern.NEWS6: Exploring Pharmaceutical Stocks’ Revenue Growth Rates.NEWS7: Is Galapagos NV a Buy Now?.NEWS8: Is Galapagos NV a Buy Now?.NEWS9: A Look at the Dividends Paid by Pharma Stocks in 2018.NEWS10: Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV.NEWS11: Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV.

Answer: Decrease